Migraine Drug Sales are Expected to Almost Double Over the Next 8 Years. One Must Ask Oneself Why?
Remember When a Billion Dollars Used to Be a Lot of Money? Well It’s Not Enough for the Pharmaceutical Companies. Migraine Drug Sales are Expected to Almost Double Over the Next 8 Years. One Must Ask Oneself Why?
One of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, Decision Resources, recently reported that the market for migraine therapies will increase tremendously in the next 8 years. If all of these pharmaceutical drugs advertise how effectively they put an end to migraine pain, then why are their sales projected to almost double over the next 8 years, going from 3.3 billion to 5.8 billion by 2021.
The population is not expected to come close to doubling in this time period, so does this mean that there will be twice as many people who have migraines? Could this mean that these drugs are actually causing more migraines in the people who use them? The answer is YES!
The concept of “MOH” (medication-overuse-headaches) is well-known and written about by dozens of neurologists and headache/migraine experts in published medical journals. It basically states that using both prescription and over-the-counter drugs too often to treat migraine pain actually results in an increased number of new migraines. These additional new migraines caused by over use of these drugs are also referred to as rebound headaches.
A recent article which reported this projected increase in migraine drug sales also stated that “the largest unmet need for migraine sufferers was in the use of prophylactic options (products that prevent the migraines from occurring rather than just taking something to try to reduce the pain after a migraine has already started).
The article went on to state that no new prophylactic options are projected to be available before 2021. Fortunately, one of the best, safest, effective, non-drug options to maintaining the normal cerebrovascular function that you have on your migraine-free days, is available right now at CVS stores throughout the U.S. as wells as on CVS.com and MigreLief.com
IF YOU SUFFER CHRONIC MIGRAINES – MIGRELIEF WILL CHANGE YOUR LIFE.
Curt Hendrix, M.S., C.C.N., C.N.S.
The MigreLief collection of supplements was created by Akeso Health Sciences to help migraine sufferers of all ages. AKESO formulates world class dietary supplements that provide nutritional support for the most common health issues that concern people most, such as migraines, headaches, joint health, stress & anxiety, memory, sleeplessness, ADHD, and more. Changing lives is the reasons we wake up every day passionate about the special products we provide to our customers. Helping you to get well and stay well is our bottom line.
Sign up for priority access to coupons, specials, health tips, product announcements and more!